Cortex Stock to Trade Over the Counter
- Share via
Cortex Pharmaceuticals Inc. said Wednesday its stock has been removed from the Nasdaq SmallCap market. The shares, which have been trading below $1 since mid-October, will be traded on the low-profile over-the-counter market. The stock closed Wednesday at 44 cents a share, unchanged.
Irvine-based Cortex, a developer of therapies for neurological and psychiatric disorders, has lost money every year this decade.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
